Long-term effects of gastric bypass and duodenal switch on systemic exposure of atorvastatin (original) (raw)
Significantly altered systemic exposure to atorvastatin acid following gastric bypass surgery in morbidly obese patients
Gunn Jakobsen, Trond Jenssen, Rune Sandbu
Clinical pharmacology and therapeutics, 2009
View PDFchevron_right
The effects of gastric bypass surgery on drug absorption and pharmacokinetics
Raj Padwal
View PDFchevron_right
Impact of body weight, low energy diet and gastric bypass on drug bioavailability, cardiovascular risk factors and metabolic biomarkers: protocol for an open, non-randomised, three-armed single centre study (COCKTAIL)
Rune Sandbu
BMJ Open, 2018
View PDFchevron_right
Vitamin status after bariatric surgery: a randomized study of gastric bypass and duodenal switch
T. Olbers
The American Journal of Clinical Nutrition, 2009
View PDFchevron_right
Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial
Bruno Caramelli
Journal of Vascular Surgery, 2004
View PDFchevron_right
The effect of atorvastatin on heart rate variability and lipoproteins in patients treated with coronary bypass surgery
Erik Schmidt, Egon Toft
International Journal of Cardiology, 2006
View PDFchevron_right
Vitamin concentrations 5 years after gastric bypass
Thomas Bøhmer
European Journal of Clinical Nutrition, 2015
View PDFchevron_right
Effect of Gastric Bypass Surgery on the Absorption and Bioavailability of Metformin
Raj Padwal
Diabetes …, 2011
View PDFchevron_right
Feasibility Of A Prospective Longitudinal Mechanistic Clinical Trial Aiming To Examine The Effects Of Gastric Bypass Surgery On Intestinal Metabolism (Preprint)
Anita Courcoulas
JMIR Research Protocols
View PDFchevron_right
Failure to recapture cardioprotection with high-dose atorvastatin in coronary artery bypass surgery: a randomised controlled trial
John Yap
Basic Research in Cardiology, 2011
View PDFchevron_right
Evaluation of an In Silico PBPK Post-Bariatric Surgery Model through Simulating Oral Drug Bioavailability of Atorvastatin and Cyclosporine
Adam S Darwich
CPT: pharmacometrics & systems pharmacology, 2013
View PDFchevron_right
Effects of atorvastatin on arterial endothelial function in coronary bypass surgery
Germano Sciascio
European Journal of Cardio-Thoracic Surgery, 2005
View PDFchevron_right
Intensive Lipid-Lowering With Atorvastatin for Secondary Prevention in Patients After Coronary Artery Bypass Surgery
Andrei Breazna, David Waters
Journal of the American College of Cardiology, 2008
View PDFchevron_right
Vitamin status after gastric bypass and lifestyle intervention: a comparative prospective study
Dag Hofsø
Surgery for Obesity and Related Diseases, 2012
View PDFchevron_right
Long-term micronutrient surveillance after gastric bypass surgery in an integrated healthcare system
Kara Kallies
Surgery for Obesity and Related Diseases, 2019
View PDFchevron_right
A systematic review of drug absorption following bariatric surgery and its theoretical implications
Raj Padwal
View PDFchevron_right
Improved Levothyroxine Pharmacokinetics After Bariatric Surgery
George Markantes
View PDFchevron_right
The safety and tolerability of atorvastatin 10 mg in the Collaborative Atorvastatin Diabetes Study (CARDS)
Andrew Neil
Diabetes & vascular disease research : official journal of the International Society of Diabetes and Vascular Disease, 2008
View PDFchevron_right
Long-term effects of Roux-en-Y gastric bypass on postprandial plasma lipid and bile acids kinetics in female non diabetic subjects: A cross-sectional pilot study
Ulrike Toepel
Clinical nutrition (Edinburgh, Scotland), 2014
View PDFchevron_right
Changes in erythrocyte sedimentation rate, white blood cell count, liver enzymes, and magnesium after gastric bypass surgery
Hans-erik Johansson
Journal of obesity, 2011
View PDFchevron_right
Metabolic adaptation following gastric bypass surgery: Results from a 2-year observational study
Ruth Price
2024
View PDFchevron_right
Atorvastatin for high-risk statin-naïve patients undergoing noncardiac surgery: The Lowering the Risk of Operative Complications Using Atorvastatin Loading Dose (LOAD) randomized trial
Carolina Alboim
American Heart Journal, 2017
View PDFchevron_right
Weight Loss, Cardiovascular Risk Factors, and Quality of Life After Gastric Bypass and Duodenal Switch
Sofia Björkman
Annals of Internal Medicine, 2011
View PDFchevron_right
Substantial Decrease in Comorbidity 5 Years After Gastric Bypass
Magnus Sundbom
Annals of Surgery, 2017
View PDFchevron_right
Need for Multivitamin Use in the Postoperative Period of Gastric Bypass
Myriam Moretto
Obesity Surgery, 2008
View PDFchevron_right
Oral drug dosing following bariatric surgery: General concepts and specific dosing advice
Catherine M T Sherwin
British Journal of Clinical Pharmacology, 2021
View PDFchevron_right
Proinflammatory and oxidative stress markers in patients submitted to Roux-en-Y gastric bypass after 1 year of follow-up
Ivan Borges
European Journal of Clinical Nutrition, 2012
View PDFchevron_right
Roux-en-Y Bypass Gastroplasty: Markers of Oxidative Stress 6 Months After Surgery
Guilherme V Portari
Obesity Surgery, 2010
View PDFchevron_right
Efficacy of oral compared with intramuscular vitamin B-12 supplementation after Roux-en-Y gastric bypass: a randomized controlled trial
Frits Berends
The American journal of clinical nutrition, 2018
View PDFchevron_right
Medication and nutritional supplement use before and after bariatric surgery
Edyane Lopes
Sao Paulo Medical Journal, 2016
View PDFchevron_right